Skip to main content

Abstract

The following substances also have a long traditional history of use, however not necessarily in the treatment of anxiety. These herbs have been included as they have demonstrated some clinical evidence and may be considered as potential treatments for anxiety. It is recommended that future studies further investigate these substances in order to determine their efficacy in the treatment of anxiety.

  • Milk thistle (Silybum marianum)

  • Iranian borage (Echium amoenum)

  • Bitter orange (Citrus aurantium)

  • Echinacea (Echinacea spp.)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Paul A, Cox PA. An ethnobotanical survey of the uses for Citrus aurantium (Rutaceae) in Haiti. Econ Bot. 1995;49(3):249–56.

    Article  Google Scholar 

  2. Carvalho-Freitas MIR, Costa M. Anxiolytic and sedative effects of extracts and essential oil from Citrus Aurantium L. Biol Pharm Bull. 2002;25(12):1629–33.

    Article  CAS  PubMed  Google Scholar 

  3. Goes TC, Antunes FD, Alves PB, Teixeira-Silva F. Effect of sweet orange aroma on experimental anxiety in humans. J Altern Complement Med. 2012;18(8):798–804.

    Article  PubMed  Google Scholar 

  4. Namazi M, Akbari SAA, Mojab F, Talebi A, Majd HA, Jannesaria S. Effects of Citrus Aurantium (Bitter Orange) on the severity of first-stage labor pain. Iran J Pharm Res. 2014;13(3):1011–8.

    PubMed  PubMed Central  Google Scholar 

  5. Namazi M, Amir Ali Akbari S, Mojab F, Talebi A, Alavi Majd H, Jannesari S. Aromatherapy with Citrus aurantium oil and anxiety during the first stage of labor. Iran Red Crescent Med J. 2014;16(6):e18371.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cho MY, Min ES, Hur MH, Lee MS. Effects of aromatherapy on the anxiety, vital signs, and sleep quality of percutaneous coronary intervention patients in intensive care units. Evid Based Complement Alternat Med eCAM. 2013;2013:381381.

    PubMed  Google Scholar 

  7. Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci. 2012;9(7):527–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Costa CA, Cury TC, Cassettari BO, Takahira RK, Flório JC, Costa M. Citrus aurantium L. essential oil exhibits anxiolytic- like activity mediated by 5-HT1A-receptors andreduces cholesterol after repeated oral treatment. BMC Complementary Altern Med. 2013;13(42):1–10.

    Article  Google Scholar 

  9. Pultrini Ade M, Galindo LA, Costa M. Effects of the essential oil from Citrus aurantium L. in experimental anxiety models in mice. Life Sci. 2006;78(15):1720–5.

    Article  PubMed  Google Scholar 

  10. Leite MP, Fassin Jr J, Baziloni F, Almeida RN, Mattei R, Leite JR. Behavioral effects of essential oil of Citrus aurantium L. inhalation in rats. Braz J Pharmacognosy. 2008;18(Supp):661–6.

    CAS  Google Scholar 

  11. Khosravi M, Khakpour S, Adibi L, Jahromy MH. A study of the effect of Citrus aurantium L. essential oil on anxiety and its interaction with GABAergic pathways in male mice. J Behav Brain Sci. 2014;04(10):470–6.

    Article  CAS  Google Scholar 

  12. Akhlaghi M, Shabanian G, Rafieian-Kopaei M, Parvin N, Saadat M. Citrus aurantium blossom and preoperative anxiety. RevBrasAnestesiol. 2011;61(6):702–12.

    Google Scholar 

  13. Haller J, Freund TF, Pelczer KG, Furedi J, Krecsak L, Zambori J. The anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteers. Phytother Res. 2013;27(1):54–61.

    Article  PubMed  Google Scholar 

  14. Kindscher K. Ethnobotany of purple coneflower (Echinacea angustifolia, Astraceae) and other echinacea species. Econ Bot. 1989;43(4):498–507.

    Article  Google Scholar 

  15. Woelkart K, Baur R. The role of alkamides as an active principle of echinacea. Planta Med. 2007;73:615–23.

    Article  CAS  PubMed  Google Scholar 

  16. Tambaro S, Bortolato M. Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. CNS Drugs Discov. 2012;7(1):25–40.

    Article  CAS  Google Scholar 

  17. Hájos N, Holderith N, Németh B, Papp OI, Szabó GG, Zemankovics R, et al. The effects of an echinacea preparation on synaptic transmission and the firing properties of CA1 pyramidal cells in the hippocampus. Phytother Res. 2012;26(3):354–62.

    PubMed  Google Scholar 

  18. Haller J, Hohmann J, Freund TF. The effect of Echinacea preparations in three laboratory tests of anxiety: comparison with chlordiazepoxide. Phytother Res. 2010;24(11):1605–13.

    Article  CAS  PubMed  Google Scholar 

  19. Rabbani M, Sajjadi SE, Khalili S. A lack of tolerance to the anxiolytic action of Echium amoenum. Res Pharm Sci. 2011;6(2):101–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Gholamzadeh S, Zare S, Ikhanipoor M. Anxiolytic effect of Echium amoenum during different treatment courses. Res Biol Sci. 2008;3(2):176–8.

    Google Scholar 

  21. Gholamzadeh S, Zare S, Ilkhanipoor M. Evaluation of the anxiolytic effect of Echium amoenum petalsextract, during chronic treatment in rat. Res Pharm Sci. 2007;2(2):91–5.

    Google Scholar 

  22. Rabbani M, Sajjadi SE, Vaseghi G, Jafarian A. Anxiolytic effects of Echium amoenum on the elevated plus-maze model of anxiety in mice. Fitoterapia. 2004;75(5):457–64.

    Article  CAS  PubMed  Google Scholar 

  23. Shafaghi B, Naderi N, Tahmasb L, Kamalinejad M. Anxiolytic effect of Echium amoenum L. in Mice. Iran J Pharm Res. 2002;1:37–41.

    Google Scholar 

  24. Sayyah M, Boostani H, Pakseresht S, Malaieri A. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1513–6.

    Article  CAS  PubMed  Google Scholar 

  25. Sayyah M, Siahpoosh A, Khalili H, Malaieri A, Samaee H. A double-blind, placebo-controlled study of the aqueous extract ofEchium amoenum for patients with general anxiety disorder. Iran J Pharm Res. 2012;11(2):697–701.

    PubMed  PubMed Central  Google Scholar 

  26. Sayyah M, Sayyah M, Kamalinejad M. A preliminary randomized double blind clinical trial on the efficacy ofaqueous extract of Echium amoenum in the treatment of mild to moderatemajor depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30:166–9.

    Article  Google Scholar 

  27. Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res. 2010;24(10):1423–32.

    Article  CAS  PubMed  Google Scholar 

  28. Bahmani M, Shirzad H, Rafieian S, Rafieian-Kopaei M. Silybum marianum: beyond Hepatoprotection. J Evid Based Complementary Altern Med. 2015;20(4):292–301.

    Article  CAS  PubMed  Google Scholar 

  29. Felter HW, Lloyd JU. King’s American dispensatory. 1898.

    Google Scholar 

  30. Mosaddegh M, Naghibi F, Moazzeni H, Pirani A, Esmaeili S. Ethnobotanical survey of herbal remedies traditionally used in Kohghiluyeh va Boyer Ahmad province of Iran. J Ethnopharmacol. 2012;141(1):80–95.

    Article  PubMed  Google Scholar 

  31. Kroll DJ, Shaw HS, Oberlies NH. Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther. 2007;6(2):110–9.

    Article  CAS  PubMed  Google Scholar 

  32. Osuchowski MF, Johnson VJ, He Q, Sharma RP. Alterations in regional brain neurotransmitters by silymarin, a natural antioxidant flavonoid mixture, in BALB/c mice. Pharmaceutical Biol. 2004;42(4–5):384–9.

    Article  CAS  Google Scholar 

  33. Lu P, Mamiya T, Lu L, Mouri A, Niwa M, Kim HC, et al. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment. Behav Brain Res. 2010;207(2):387–93.

    Article  CAS  PubMed  Google Scholar 

  34. Mazzio EA, Harris N, Soliman KFA. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Medica. 1998;64(7):603–6.

    Article  CAS  PubMed  Google Scholar 

  35. Solati J, Yaghmaei P, Mohammdadi K. Role of the 5-HT1A serotonergic system in anxiolytic-like effects of Silymarin. Neurophysiol. 2012;44(1):49–55.

    Article  CAS  Google Scholar 

  36. Sayyah M, Boostani H, Pakseresht S, Malayeri A. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of obsessive−compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2010;34(2):362–5.

    Article  CAS  Google Scholar 

  37. Gordon A, Hobbs DA, Bowden DS, Bailey MJ, Mitchell J, Francis AJP, et al. Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2006;21(1):275–80.

    Article  PubMed  Google Scholar 

  38. Grant JE, Odlaug BL. Silymarin treatment of obsessive-compulsive spectrum disorders. J Clin Psychopharmacol. 2015;35(3):340–2.

    Article  PubMed  Google Scholar 

  39. Ardjomand-Woelkart K, Bauer R. Review and assessment of medicinal safety data of orally used Echinacea preparations. Planta Medica. 2016;82(01/02):17–31.

    CAS  PubMed  Google Scholar 

  40. Sarris J, Ng C, Schweitzer I. “Omic” genetic technologies for herbal medicines in psychiatry. Phytother Res. 2011;26:522–7.

    Article  PubMed  Google Scholar 

  41. Ulrich-Merzenich G, Zeitler H, Jobst D, Panek D, Vetter H, Wagner H. Application of the “-Omic-” technologies in phytomedicine. Phytomedicine. 2007;14(1):70–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Erica McIntyre .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

McIntyre, E., Camfield, D.A., Sarris, J. (2017). Potential Herbal Anxiolytics. In: Camfield, D., McIntyre, E., Sarris, J. (eds) Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-42307-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42307-4_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42305-0

  • Online ISBN: 978-3-319-42307-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics